AstraZeneca to issue trial update after US agency questions 'outdated' data

AstraZeneca will release the most up-to-date results from its latest Covid-19 vaccine trial within 48 hours after US health officials publicly criticised the drugmaker for using outdated information in a press release earlier this week. AstraZeneca said results published on Monday were based on an interim analysis of data through Feb 17.

The company said on Tuesday it would "immediately engage" with the independent panel monitoring the trial to share its primary analysis using the most up-to-date efficacy data. The move.

This article is no longer available in our repository.

There could be multiple reasons for this.